Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
Palo Alto Networks
PANW
|
+$957M |
| 3 |
Medtronic
MDT
|
+$433M |
| 4 |
Pinterest
PINS
|
+$422M |
| 5 |
Colgate-Palmolive
CL
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.38B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$967M |
| 3 |
Apple
AAPL
|
+$847M |
| 4 |
Meta Platforms (Facebook)
META
|
+$700M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$576M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.9% |
| 2 | Financials | 7.33% |
| 3 | Healthcare | 6.04% |
| 4 | Consumer Discretionary | 5.46% |
| 5 | Communication Services | 3.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4151
Bionano Genomics
BNGO
$13.3M
| $23K | ﹤0.01% |
28
-57
| -67% | -$58.6K |
|
4152
iShares MSCI France ETF
EWQ
$345M
| $23K | ﹤0.01% |
765
| – | – |
|
4153
flyExclusive Inc Warrants
FLYX.WS
| $23K | ﹤0.01% |
166,666
| – | – |
|
4154
nLIGHT
LASR
$3.17B
| $23K | ﹤0.01% |
2,203
-5,064
| -70% | -$65.4K |
|
4155
908 Devices
MASS
$364M
| $23K | ﹤0.01% |
1,098
-2,544
| -70% | -$42.7K |
|
4156
National CineMedia
NCMI
$378M
| $23K | ﹤0.01% |
2,575
-996
| -28% | -$16.8K |
|
4157
Stoneridge
SRI
$213M
| $23K | ﹤0.01% |
1,322
-3,039
| -70% | -$57.7K |
|
|
THR
4158
DELISTED
Thermon Group Holdings
THR
| $23K | ﹤0.01% |
1,662
-3,844
| -70% | -$59.3K |
|
|
TPIC
4159
DELISTED
TPI Composites
TPIC
| $23K | ﹤0.01% |
1,836
-4,362
| -70% | -$57.2K |
|
|
AKTS
4160
DELISTED
Akoustis Technologies Inc
AKTS
| $23K | ﹤0.01% |
6,066
-6,517
| -52% | -$28.9K |
|
|
TBIO
4161
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
| $23K | ﹤0.01% |
695
-390
| -36% | -$26.9K |
|
|
NWLI
4162
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $23K | ﹤0.01% |
114
-314
| -73% | -$64.3K |
|
|
VLDR
4163
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
| $23K | ﹤0.01% |
23,991
-4,091
| -15% | -$7.07K |
|
|
POSH
4164
DELISTED
Poshmark, Inc. Class A Common Stock
POSH
| $23K | ﹤0.01% |
2,307
+1,381
| +149% | +$15.9K |
|
|
VZIO
4165
DELISTED
VIZIO Holding Corp.
VZIO
| $23K | ﹤0.01% |
3,469
+1,993
| +135% | +$16.3K |
|
4166
American Resources Corp
AREC
$293M
| $22K | ﹤0.01% |
15,000
| – | – |
|
4167
Arrow Financial
AROW
$652M
| $22K | ﹤0.01% |
732
-1,727
| -70% | -$51.9K |
|
|
BASE
4168
DELISTED
Couchbase
BASE
| $22K | ﹤0.01% |
1,330
-2,700
| -67% | -$42.6K |
|
|
CDTX
4169
DELISTED
Cidara Therapeutics
CDTX
| $22K | ﹤0.01% |
2,209
-162
| -7% | -$2K |
|
|
CMBM
4170
DELISTED
Cambium Networks
CMBM
| $22K | ﹤0.01% |
1,528
-2,413
| -61% | -$38K |
|
4171
Focus Universal
FCUV
$3.65M
| $22K | ﹤0.01% |
+7
| New | +$23.9K |
|
4172
Global Industrial
GIC
$1.49B
| $22K | ﹤0.01% |
+652
| New | +$21.3K |
|
4173
IAMGOLD
IAG
$10.5B
| $22K | ﹤0.01% |
13,560
-86
| -0.6% | -$216 |
|
4174
Immuneering
IMRX
$292M
| $22K | ﹤0.01% |
4,160
-3,068
| -42% | -$16.4K |
|
|
MREO
4175
Mereo BioPharma
MREO
$47.3M
| $22K | ﹤0.01% |
20,000
-406,085
| -95% | -$315K |
|
Similar funds
Barclays's Q2 2022 Portfolio in Review
As of Q2 2022, Barclays held 5,544 positions worth $163B, up 28% from $128B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Barclays deployed $63.1B of net new capital in Q2 2022, opening 560 new positions and adding to 1,332 existing holdings. Its largest new stake was Fisker Inc.: 3,607,227 shares worth $30.9M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.38B trimmed.
- Barclays's largest Q2 2022 buy was Fisker Inc.: 3,607,227 shares worth $30.9M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q2 2022, an estimated $1.04B increase.
- Barclays's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.38B.
- Barclays fully exited Cerner Corp in Q2 2022, selling an estimated $432M.
- Barclays's ten largest holdings make up 39% of its $163B portfolio in Q2 2022.
- Barclays opened 560 new positions and closed 413 in Q2 2022.
- Barclays's portfolio value rose 28% quarter-over-quarter to $163B.
Based on Barclays's 13F filing for Q2 2022, filed 12 Aug 2022.